Benzene-induced hematotoxicity enhances the self-renewal ability of HSPCs in Mll-Af9 mice

被引:0
|
作者
Zhou, Jin [1 ,2 ]
Sui, Pinpin [3 ,4 ,5 ]
Zhao, Jianxin [1 ,6 ]
Cheng, Xiurong [1 ,2 ]
Yu, Tao [1 ,2 ]
Cui, Shiwei [1 ,2 ]
Song, Xiangrong [7 ]
Xing, Caihong [1 ,2 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Natl Inst Occupat Hlth & Poison Control, Key Lab Chem Safety & Hlth, Beijing, Peoples R China
[2] China State Key Lab Trauma Burn & Combined Injury, Beijing, Peoples R China
[3] Chinese Acad Sci, Beijing Inst Genom, Collaborat Innovat Ctr Genet & Dev, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China
[4] China Natl Ctr Bioinformat, Beijing, Peoples R China
[5] Univ Chinese Acad Sci, Beijing, Peoples R China
[6] Sichuan Univ, West China Univ Hosp 2, Natl Off Maternal & Child Hlth Surveillance China, Chengdu, Peoples R China
[7] Guangdong Prov Hosp Occupat Dis Prevent & Treatmen, Inst Toxicol, Guangzhou, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Benzene; Hematotoxicity; Hematopoietic stem and progenitor cells; Self-renewal ability; AML; HEMATOPOIETIC STEM-CELLS; MYELOID-LEUKEMIA; NEOPLASMS; WORKERS; HOXB4; MLL;
D O I
10.1016/j.tox.2025.154061
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Patients with benzene-induced leukemia undergo a continuous transformation from myelosuppression to malignant proliferation. However, the underlying mechanisms in this process remain unknown. Our previous studies have shown that the pathways involved in self-renewal capacity of bone marrow (BM) cells in Mll-Af9 mice exposed to benzene for life are significantly activated after severe blood toxicity. In order to investigate the hematotoxicity effects of benzene on the self-renewal capacity of HSCs, Mll-Af9 chimeric mice were exposed to benzene and hematological parameters were dynamically monitored after benzene exposure. Transcriptomic analysis were used to analyze different time points during benzene exposure and after competitive bone marrow transplantation (BMT). Results showed that despite severe hematotoxicity in mice, but the chimerism rate of Mll-Af9 cells in peripheral blood (PB) cells was significantly increased after 10 weeks benzene exposure (P < 0.001). After competitive BMT, the chimerism rate of Mll-Af9 cells from 10 weeks benzene-exposed mice was gradually increased and significantly surpassed that of the control at 26 weeks of bone marrow reconstruction (benzene group 86 % VS control group 78 %, P = 0.03). Transcriptome analysis revealed that the expression levels of self-renewal related genes, such as Hox genes (Hoxb4, Hoxa7, Hoxa10), Mecom and Ms4a in BM cells of 10 weeks benzene-exposed mice were relatively higher compared to those in the control group, but no significant difference were observed. Interestingly, Hoxa7, Hoxa10 and Mecom were significantly up-regulated at 26 weeks after bone marrow transplantation. In conclusion, our study suggests that abnormal expression of self-renewal-related genes may be potential early biomarkers for benzene-induced hematotoxicity. This hematotoxicity may contribute to the acquisition of evolutionary advantages by leukemic precursor cells and accelerate malignant transformation.
引用
收藏
页数:10
相关论文
共 11 条
  • [1] Differential expression of Mll-AF9 up-regulated genes correlates with enhanced self-renewal of hematopoietic progenitors.
    Kumar, Ashish R.
    Hudson, Wendy A.
    Chen, Weili
    Staggs, Rodney A.
    Lamblin, Anne-Francoise
    Kersey, John H.
    BLOOD, 2006, 108 (11) : 220A - 220A
  • [2] Mll-AF9 imparts extensive self renewal and myeloid attributes to committed lymphoid progenitors
    Kumar, A. R.
    Chen, W.
    Hudson, W. A.
    Kersey, J. H.
    EXPERIMENTAL HEMATOLOGY, 2006, 34 (09) : 36 - 36
  • [3] The Mll-AF9 knock-in fusion gene results in reprogramming and enhanced self-renewal of hematopoietic progenitors, especially in the HSC and CLP populations.
    Chen, Weili
    Kumar, Ashish R.
    Hudson, Wendy A.
    Li, Quanzhi
    Kersey, John H.
    BLOOD, 2006, 108 (11) : 413A - 413A
  • [4] Chronic benzene exposure impairs the self-renewal capacity of HSPCs in C57BL/6 mice
    Zhang, Yan
    Zhou, Jin
    Zhao, Jianxin
    Cheng, Xiurong
    Xing, Caihong
    TOXICOLOGY RESEARCH, 2025, 14 (01)
  • [5] The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
    J Shi
    E Wang
    J Zuber
    A Rappaport
    M Taylor
    C Johns
    S W Lowe
    C R Vakoc
    Oncogene, 2013, 32 : 930 - 938
  • [6] The Polycomb complex PRC2 supports aberrant self-renewal in a mouse model of MLL-AF9;NrasG12D acute myeloid leukemia
    Shi, J.
    Wang, E.
    Zuber, J.
    Rappaport, A.
    Taylor, M.
    Johns, C.
    Lowe, S. W.
    Vakoc, C. R.
    ONCOGENE, 2013, 32 (07) : 930 - 938
  • [7] La-related protein 4B maintains murine MLL-AF9 leukemia stem cell self-renewal by regulating cell cycle progression
    Zhang, Yingchi
    Peng, Luyun
    Hu, Tianyuan
    Wan, Yang
    Ren, Yuanyuan
    Zhang, Jingliao
    Wang, Xiaojuan
    Zhou, Yuan
    Yuan, Weiping
    Wang, Qianfei
    Cheng, Tao
    Zhu, Xiaofan
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (04) : 309 - 318
  • [8] KLF4 Controls Leukemic Stem Cell Self-Renewal in MLL-AF9-Induced Acute Myeloid Leukemia
    Lewis, Andrew
    Park, Chun Shik
    Puppi, Monica
    Lacorazza, H. Daniel
    BLOOD, 2019, 134
  • [9] Activated NRAS Mediates Self-Renewal Capacity in AML by Facilitating the Mll/AF9-Specified Gene Expression Signature
    Sachs, Zohar
    Hanh Nguyen
    Hassan, Nurul Azyan Mohd
    Rathe, Susan K.
    Sachs, Karen
    Diaz-Flores, Ernesto
    Bendall, Sean C.
    Diers, Miechaleen D.
    Nolan, Garry P.
    Shannon, Kevin M.
    Largaespada, David A.
    BLOOD, 2012, 120 (21)
  • [10] MLL-AF9-and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C
    Zhu, Nan
    Chen, Mo
    Eng, Rowena
    DeJong, Joshua
    Sinha, Amit U.
    Rahnamay, Noushin F.
    Roche, Richard
    Al-Shahrour, Fatima
    Minehart, Janna C.
    Chen, Chun-Wei
    Deshpande, Aniruddha J.
    Xu, Haiming
    Chu, S. Haihua
    Ebert, Benjamin L.
    Roeder, Robert G.
    Armstrong, Scott A.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (03): : 997 - 1011